280 related articles for article (PubMed ID: 34152047)
1. Human iPSC-derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntington's disease mouse model.
Park HJ; Jeon J; Choi J; Kim JY; Kim HS; Huh JY; Goldman SA; Song J
Cell Prolif; 2021 Aug; 54(8):e13082. PubMed ID: 34152047
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
3. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.
Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H
Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cell-derived neural progenitor cell transplantation promotes regeneration and functional recovery after post-traumatic stress disorder in rats.
Liu Q; Zhang L; Zhang J
Biomed Pharmacother; 2021 Jan; 133():110981. PubMed ID: 33186796
[TBL] [Abstract][Full Text] [Related]
5. Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease.
El-Akabawy G; Rattray I; Johansson SM; Gale R; Bates G; Modo M
BMC Neurosci; 2012 Aug; 13():97. PubMed ID: 22876937
[TBL] [Abstract][Full Text] [Related]
6. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
7. Intracerebral transplantation of HLA-homozygous human iPSC-derived neural precursors ameliorates the behavioural and pathological deficits in a rodent model of ischaemic stroke.
Noh JE; Oh SH; Lee S; Lee S; Kim YH; Park HJ; Ju JH; Kim HS; Huh JY; Song J
Cell Prolif; 2020 Sep; 53(9):e12884. PubMed ID: 32713053
[TBL] [Abstract][Full Text] [Related]
8. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.
Mu S; Wang J; Zhou G; Peng W; He Z; Zhao Z; Mo C; Qu J; Zhang J
PLoS One; 2014; 9(7):e101185. PubMed ID: 25054283
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease.
Jeon I; Choi C; Lee N; Im W; Kim M; Oh SH; Park IH; Kim HS; Song J
Int J Stem Cells; 2014 May; 7(1):43-7. PubMed ID: 24921027
[TBL] [Abstract][Full Text] [Related]
11. Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington's Disease Monkey pluripotent stem cells.
Goodnight AV; Kremsky I; Khampang S; Jung YH; Billingsley JM; Bosinger SE; Corces VG; Chan AWS
Epigenetics Chromatin; 2019 Nov; 12(1):67. PubMed ID: 31722751
[TBL] [Abstract][Full Text] [Related]
12. Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury.
Pomeshchik Y; Puttonen KA; Kidin I; Ruponen M; Lehtonen S; Malm T; Åkesson E; Hovatta O; Koistinaho J
Cell Transplant; 2015; 24(9):1799-812. PubMed ID: 25203632
[TBL] [Abstract][Full Text] [Related]
13. Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington's Disease.
Gharaibeh A; Maiti P; Culver R; Heileman S; Srinageshwar B; Story D; Spelde K; Paladugu L; Munro N; Muhn N; Kolli N; Rossignol J; Dunbar GL
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333883
[TBL] [Abstract][Full Text] [Related]
14. Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease.
Al-Gharaibeh A; Culver R; Stewart AN; Srinageshwar B; Spelde K; Frollo L; Kolli N; Story D; Paladugu L; Anwar S; Crane A; Wyse R; Maiti P; Dunbar GL; Rossignol J
Front Neurosci; 2017; 11():628. PubMed ID: 29209158
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
16. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J
Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
[TBL] [Abstract][Full Text] [Related]
18. Human neural progenitors derived from integration-free iPSCs for SCI therapy.
Liu Y; Zheng Y; Li S; Xue H; Schmitt K; Hergenroeder GW; Wu J; Zhang Y; Kim DH; Cao Q
Stem Cell Res; 2017 Mar; 19():55-64. PubMed ID: 28073086
[TBL] [Abstract][Full Text] [Related]
19. Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease.
Cisbani G; Saint-Pierre M; Cicchetti F
Cell Transplant; 2014; 23(10):1267-78. PubMed ID: 23768945
[TBL] [Abstract][Full Text] [Related]
20. Characterization of subventricular zone-derived progenitor cells from mild and late symptomatic YAC128 mouse model of Huntington's disease.
Silva AC; Ferreira IL; Hayden MR; Ferreiro E; Rego AC
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):34-44. PubMed ID: 28939435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
